Obi Greenman
Directeur Général chez CERUS CORPORATION
Fortune : 5 M $ au 30/04/2024
Postes actifs de Obi Greenman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CERUS CORPORATION | Directeur/Membre du Conseil | 21/04/2011 | - |
| Directeur Général | 21/04/2011 | - | |
| President | 21/04/2011 | - | |
| Corporate Officer/Principal | 01/01/1999 | 01/08/2008 | |
| Sales & Marketing | 01/08/2008 | 21/04/2011 |
Historique de carrière de Obi Greenman
Anciens postes connus de Obi Greenman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2010 | 11/08/2023 |
| Independent Dir/Board Member | 01/06/2010 | 11/08/2023 | |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/1995 | 01/01/1995 |
| CHINOOK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 23/06/2011 | - |
| Independent Dir/Board Member | 01/06/2010 | - |
Formation de Obi Greenman
| Stanford University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CERUS CORPORATION | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Bourse
- Insiders
- Obi Greenman
- Expérience
